Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,358 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Unresolved issues in prophylaxis.
Brown SA, Aledort LM, Astermark J, Berntorp E, van den Berg M, Blanchette V, Donfield S, Gringeri A, Hilgartner M, Kulkarni R, Leissinger C, Negrier C, Nuss R, Petterson H, Petrini P, Poulios N, Schramm W; Round Table Group. Brown SA, et al. Among authors: van den berg m. Haemophilia. 2002 Nov;8(6):817-21. doi: 10.1046/j.1365-2516.2002.00685.x. Haemophilia. 2002. PMID: 12410654 No abstract available.
Outcome measures in haemophilia: more than just factor levels.
Bohn RL, Schramm W, Bullinger M, van den Berg M, Blanchette V. Bohn RL, et al. Among authors: van den berg m. Haemophilia. 2004 Mar;10 Suppl 1:2-8. doi: 10.1111/j.1355-0691.2004.00873.x. Haemophilia. 2004. PMID: 14987243 Review. No abstract available.
Physical therapy and imaging outcome measures in a haemophilia population treated with factor prophylaxis: current status and future directions.
Manco-Johnson MJ, Pettersson H, Petrini P, Babyn PS, Bergstrom BM, Bradley CS, Doria AS, Feldman BM, Funk S, Hilliard P, Kilcoyne R, Lundin B, Nuss R, Rivard G, Schoenmakers MA, Van den Berg M, Wiedel J, Zourikian N, Blanchette VS. Manco-Johnson MJ, et al. Among authors: van den berg m. Haemophilia. 2004 Oct;10 Suppl 4:88-93. doi: 10.1111/j.1365-2516.2004.00978.x. Haemophilia. 2004. PMID: 15479378 Review.
Cost effectiveness of haemophilia treatment: a cross-national assessment.
Lippert B, Berger K, Berntorp E, Giangrande P, van den Berg M, Schramm W, Siebert U; European Haemophilia Economic Study Group. Lippert B, et al. Among authors: van den berg m. Blood Coagul Fibrinolysis. 2005 Oct;16(7):477-85. doi: 10.1097/01.mbc.0000178830.39526.ff. Blood Coagul Fibrinolysis. 2005. PMID: 16175006
Hemophilia joint health score reliability study.
Hilliard P, Funk S, Zourikian N, Bergstrom BM, Bradley CS, McLimont M, Manco-Johnson M, Petrini P, van den Berg M, Feldman BM. Hilliard P, et al. Among authors: van den berg m. Haemophilia. 2006 Sep;12(5):518-25. doi: 10.1111/j.1365-2516.2006.01312.x. Haemophilia. 2006. PMID: 16919083
Treatment of children with haemophilia in Europe: a survey of 20 centres in 16 countries.
Ljung R, Aronis-Vournas S, Kurnik-Auberger K, van den Berg M, Chambost H, Claeyssens S, van Geet C, Glomstein A, Hann I, Hill F, Kobelt R, Kreuz W, Mancuso G, Muntean W, Petrini P, Rosado L, Scheibel E, Siimes M, Smith O, Tusell J. Ljung R, et al. Among authors: van den berg m, van geet c. Haemophilia. 2000 Nov;6(6):619-24. doi: 10.1046/j.1365-2516.2000.00427.x. Haemophilia. 2000. PMID: 11122385
The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany.
Berntorp E, Dargaud Y, Hart D, Lobet S, Mancuso ME, d'Oiron R, Perry D, Pollard D, van den Berg M, Blatný J, Chambost H, Doria AS, Holme PA, Kaczmarek R, Mantovani L, McLaughlin P, Nanayakkara L, Petrini P, Sannié T, Laane E, Maia R, Dettoraki A, Farrell A, Halimeh S, Raza S, Taylor S. Berntorp E, et al. Among authors: van den berg m. Eur J Haematol. 2017 Jan;98 Suppl 85:1-15. doi: 10.1111/ejh.12828. Eur J Haematol. 2017. PMID: 28101938 Free article.
Comparative pharmacokinetics of plasma- and albumin-free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age-related differences and implications for dose tailoring.
Björkman S, Blanchette VS, Fischer K, Oh M, Spotts G, Schroth P, Fritsch S, Patrone L, Ewenstein BM; Advate Clinical Program Group; Collins PW. Björkman S, et al. J Thromb Haemost. 2010 Apr;8(4):730-6. doi: 10.1111/j.1538-7836.2010.03757.x. J Thromb Haemost. 2010. PMID: 20398185 Free PMC article.
1,358 results